chrysalis_top_new
chrysalis_top_new
Slide 2
Slide 2
Slide 3
Slide 3

RELEVANT PUBLICATIONS

Olszewska-Pazdrak B, McVicar, SD, Rayavara K, Moya SM, Kantara K, Gammarano C, Olszewska P, Fuller GM, Sower LE and Carney DH. Nuclear Countermeasure Activity of TP508 Linked to Restoration of Endothelial Function and Acceleration of DNA Repair.  Rad Res. 186: 162-174. http://www.chrysbio.com/wp-content/uploads/2016/08/Nuclear-Countermeasure-Activity-of-TP508.pdf

Kantara, C., Moya, S.M., Houchen, C.W., Umar, S., Ullrich, R.L., Singh, P. and Carney, D.H. (2015) Novel regenerative peptide TP508 mitigates radiation-induced gastrointestinal damage by activating stem cells and preserving crypt integrity. Lab Invest. Aug 17. TP508 Mitigates Radiation Induced GI Damage

 

PUBLICATIONS BY Dr. Darrell CARNEY

https://www.ncbi.nlm.nih.gov/pubmed/?term=Carney+DH

 

Chrysalis BioTherapeutics, Inc. is committed to helping improve people's lives through innovation.
Skip to toolbar